PillRx only · Injection, Solution · Intramuscular
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
85
Rx · 2026 Q1
333
Units dispensed
+254%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Provepharm Inc. | unknown | 2 | SUPPLYING |
| MILLA PHARMACEUTICALS INC. | unknown | 2 | SUPPLYING |
| Baxter Healthcare Corporation | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 22, 2024RECALLRecall (Class II): Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm…
Discoloration — Recalling firm: Provepharm Inc. — Nationwide within the United States